To understand how RENCA macrobead-secreted tumor-inhibitory proteins regulate MEF2 expression, we explored the activity of cell-surface receptors, specifically TGF-β/SMAD, BMP and EGFR, as they have previously been shown to converge on MEF2 transcriptional regulation. The gene discussed is CD177; the disease is neoplasm.